These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 4017948

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P, Snochowski M, Dahlberg E, Bression D, Högberg B, Gustafsson JA.
    J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Role of 5α-reductase inhibitors in benign prostatic diseases.
    Azzouni F, Mohler J.
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
    [Abstract] [Full Text] [Related]

  • 49. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2.
    Guarna A, Belle C, Machetti F, Occhiato EG, Payne AH, Cassiani C, Comerci A, Danza G, De Bellis A, Dini S, Marrucci A, Serio M.
    J Med Chem; 1997 Mar 28; 40(7):1112-29. PubMed ID: 9089333
    [Abstract] [Full Text] [Related]

  • 50. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP, Bruchovsky N, Shnitka TK, Rennie PS, Comeau TL.
    Acta Endocrinol (Copenh); 1980 Jun 28; 94(2):284-8. PubMed ID: 6158242
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Anti-5 alpha-reductase autoantibodies in the serum of patients with prostatic cancer.
    Liang T, Hiipakka RA, Stebbins J, Liao S.
    J Clin Endocrinol Metab; 1990 Dec 28; 71(6):1666-8. PubMed ID: 2229323
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effects.
    Blohm TR, Laughlin ME, Benson HD, Johnston JO, Wright CL, Schatzman GL, Weintraub PM.
    Endocrinology; 1986 Sep 28; 119(3):959-66. PubMed ID: 3732173
    [Abstract] [Full Text] [Related]

  • 57. The distribution of 5 alpha-reductase and 3 alpha(beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland.
    Habib FK, Beynon L, Chisholm GD, Busuttil A.
    Steroids; 1983 Jan 28; 41(1):41-53. PubMed ID: 6197780
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.